简介：AIM:Toanalyzetheapplicationofmicrobubblecontrasttechnologyinthetreatmentofophthalmicdiseases,mainlyanalyzingitsadvantagesandexistingproblems.METHODS:Atotalof30representativeliteraturesabouttheapplicationofultrasoundcontrastagentingenetargetedtherapyathomeandabroadwerecollected,andfocusingonsortingouttheliteraturereportingthetreatmentofophthalmicdiseaseswithmicrobubblecontrasttechnologyinrecentyears,thenrecallingitsadvantagesandproblems,finallymakingreasonableassessmentonexistingproblemsandproposingpossiblesolutionstotheproblems.RESULTS:Duetoitsuniquesafetyandefficacy,thetreatmentofophthalmicdiseaseswithmicrobubblecontrasttechnologyhasincreasinglydrawntheattentionofclinicians,buttworelevantissuesshouldbeconsidered:first,thenatureofcontrastagentandthechoiceofcorrespondingultrasoundparameters;second,relativeincidenceoftissuebleeding,intravascularhemolysis,moderateorsevereallergyaswellasothersideeffects.CONCLUSION:Microbubblemaybecomethecarrieroftargetedtherapy,andasakindofnewnon-invasivedeliverysystem,theultrasoundcontrastagenthasbroadapplicationprospects,butitsapplicationinophthalmicresearchisstillinitsinitialstageandthesafetyofcontrast-enhancedultrasoundstillneedsfurtherstudy.

简介：AIM:TotrainTibetanmonkey(Macacathibetana)forintraocularpressure(IOP)measurementinconsciousstateandobtainnormalIOPinconsciousTibetanMacaque.·METHODS:Thetrainingwasbasedonaward-conditionedbehavior.Foodstimulationandhuman-animalinteractionwereusedinthistraining.·RESULTS:TrainedTibetanmonkeyscalmlyacceptedIOPmeasurementbytheTonoVet?誖reboundtonometerwithoutsedationoranesthesiaandtheirIOPvaluesweresimilartootherprimates.·CONCLUSION:Human-cultivatedThibetanmonkeysaretamable,andcanbeusedforbiomedicalresearchsuchasophthalmicresearchwithoutanesthesia.

简介：AIM:ToexploretheinhibitoryeffectofasustainedcyclosporinA(CsA)deliverymicrosphere(CsA-MS)onposteriorcapsularopacification(PCO)inrabbiteyesaftercataractextraction.·METHODS:TwentyNewZealandwhiterabbitsacceptedcataractextractionplusintraocularlensimplantationandtheirlefteyeswereintraoperativelyinjectedCsA-MSpreparedusingpolymerpolylactioglycolicacid(PLGA)asacarrierandtheirrighteyeswereinjectedwithemptyMS.Thechangesincornea,anteriorchamberreaction,intraocularpressure,PCOandCsAconcentrationinaqueoushumorwereexaminedpostoperativelyandalltheeyeswereenucleated3monthsaftersurgeryforhistopathologicalandmorphologicalexaminationwithlightmicroscopyandelectronmicroscopy.·RESULTS:Conjunctivalhyperemia,cornealedema,intraocularpressureandanteriorchamberresponseofexperimentalandcontroleyesweresimilar,whilePCOinCsAMSinjectedeyeswasgreatlyimprovedcomparedwiththatincontroleyes.PosteriorcapsulesinCsA-MSinjectedeyesweresmoothandlensepithelialcells(LEC)didnotproliferatesignificantly(P>0.05),whileLECinposteriorcapsuleofcontroleyeshaddifferentdegreesofproliferationandcorticalregeneration.LECinCsA-MSinjectedeyeswerenotfunctionallyactiveandunderwentapoptosis,whereasLECincontroleyeswerefunctionallyactive(F-test,P=0.025).Inaddition,thecornealultrastructureshowednodifferencesbetweenCsA-MSandMSinjectedeyes.CONCLUSION:CsA-MShashighbioavailabilityinrabbiteyesandcouldinhibitpostoperativePCOoccurrenceanddevelopmentduringthestudyperiod,suggestingthatCsA-MSmaybeapromising,effectiveandsafeadministrationroutetopreventPCOinclinic.